Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology EquipmentInfectious Disease

PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1351344

Cover Image

PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1351344

Bacterial Disease Diagnostics Market Size- By Type, By Product, By Technology, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

PUBLISHED:
PAGES: 221 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Group License)
USD 5650
PDF (Company License)
USD 7450

Add to Cart

Description

Table of Contents

Introduction and Overview

According to SPER Market Research, 'Bacterial Disease Diagnostics Market Size- By Type, By Product, By Technology, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Bacterial Disease Diagnostics Market is predicted to reach with a CAGR of 6.5%.

The several forms of bacteria. However, the majority of them are good for the body while some of them are contagious. Pathogens include all bacteria that are responsible for infectious diseases. To prevent the needless use of antibiotics and to target the right therapy, an accurate diagnosis of bacterial infection is essential. In order to confirm a bacterial infection, more than one diagnostic method is typically needed because it involves the presence of germs as well as inflammation or systemic dysfunction.

Furthermore, the new coronavirus that causes COVID-19 has sparked support from governments all over the world for laboratories to expedite testing procedures. Although the pandemic reduced revenues in several industries, its application in COVID-19 testing helped the market for infectious illness diagnostics. The regulatory authorities hastened the licencing of COVID-19 diagnostic products.

Scope of the Report

Report Metric Details:

  • Market size available for years: 2019-2033
  • Base year considered: 2022
  • Forecast period: 2023-2033
  • Segments covered: By Type, By Product, By Technology, By End User
  • Regions covered: North America, Asia-Pacific, Latin America, Middle East & Africa and Europe
  • Companies Covered: Abbott Laboratories, Accelerate Diagnostics Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Bruker Corp., Danaher Corp., Meridian Bioscience Inc., Perkin Elmer Inc., Quest Diagnostics Inc., and Takara Bio Inc., Others

Market Segmentation:

  • By Type: Based on the Type, Global Bacterial Disease Diagnostics Market is segmented as; Bacterial Skin Infections, Foodborne Infections, Sexually Transmitted Infections.
  • By Product: Based on the Product, Global Bacterial Disease Diagnostics Market is segmented as; Consumables, Instruments.
  • By End User: Based on the End User, Global Bacterial Disease Diagnostics Market is segmented as; Hospitals, Labs, Research Centres.
  • By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.
Show more
Product Code: HLCA2357

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPER's internal database
    • 2.1.4. Premium insight from KOL's
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. COVID-19 Impacts of the Global Bacterial Disease Diagnostics Market

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTER's Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Global Bacterial Disease Diagnostics Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Bacterial Disease Diagnostics Market

7. Global Bacterial Disease Diagnostics Market, By Type (USD Million)

  • 7.1. Global Bacterial Disease Diagnostics Market Value Share and Forecast, By Type, 2023-2033
  • 7.2. Bacterial Skin Infections
  • 7.3. Foodborne Infections
  • 7.4. Sexually Transmitted Infections

8. Global Bacterial Disease Diagnostics Market, By Product (USD Million)

  • 8.1. Global Bacterial Disease Diagnostics Market Value Share and Forecast, By Product, 2023-2033
  • 8.2. Consumables
  • 8.3. Instruments

9. Global Bacterial Disease Diagnostics Market, By Technology (USD Million)

  • 9.1. Global Bacterial Disease Diagnostics Market Value Share and Forecast, By Technology, 2023-2033
  • 9.2. DNA Microarray
  • 9.3. Immunodiagnostics
  • 9.4. Isothermal Nucleic Acid Amplification Technology
  • 9.5. Polymerase Chain Reaction

10. Global Bacterial Disease Diagnostics Market, By End User (USD Million)

  • 10.1. Global Bacterial Disease Diagnostics Market Value Share and Forecast, By End User, 2023-2033
  • 10.2. Hospitals
  • 10.3. Labs
  • 10.4. Research Centres

11. Global Bacterial Disease Diagnostics Market Forecast, 2019-2033 (USD Million)

  • 11.1. Global Bacterial Disease Diagnostics Market Size and Market Share

12. Global Bacterial Disease Diagnostics Market, By Type, 2019-2033 (USD Million)

  • 12.1. Global Bacterial Disease Diagnostics Market Size and Market Share By Type (2019-2026)
  • 12.2. Global Bacterial Disease Diagnostics Market Size and Market Share By Type (2027-2033)

13. Global Bacterial Disease Diagnostics Market, By Product, 2019-2033 (USD Million)

  • 13.1. Global Bacterial Disease Diagnostics Market Size and Market Share By Product (2019-2026)
  • 13.2. Global Bacterial Disease Diagnostics Market Size and Market Share By Product (2027-2033)

14. Global Bacterial Disease Diagnostics Market, By Technology, 2019-2033 (USD Million)

  • 14.1. Global Bacterial Disease Diagnostics Market Size and Market Share By Technology (2019-2026)
  • 14.2. Global Bacterial Disease Diagnostics Market Size and Market Share By Technology (2027-2033)

15. Global Bacterial Disease Diagnostics Market, By End User, 2019-2033 (USD Million)

  • 15.1. Global Bacterial Disease Diagnostics Market Size and Market Share By End User (2019-2026)
  • 15.2. Global Bacterial Disease Diagnostics Market Size and Market Share By End User (2027-2033)

16. Global Bacterial Disease Diagnostics Market, By Region, 2019-2033 (USD Million)

  • 16.1. Global Bacterial Disease Diagnostics Market Size and Market Share By Region (2019-2026)
  • 16.2. Global Bacterial Disease Diagnostics Market Size and Market Share By Region (2027-2033)
  • 16.3. Asia-Pacific
    • 16.3.1. Australia
    • 16.3.2. China
    • 16.3.3. India
    • 16.3.4. Japan
    • 16.3.5. South Korea
    • 16.3.6. Rest of Asia-Pacific
  • 16.4. Europe
    • 16.4.1. France
    • 16.4.2. Germany
    • 16.4.3. Italy
    • 16.4.4. Spain
    • 16.4.5. United Kingdom
    • 16.4.6. Rest of Europe
  • 16.5. Middle East and Africa
    • 16.5.1. Kingdom of Saudi Arabia
    • 16.5.2. United Arab Emirates
    • 16.5.3. Rest of Middle East & Africa
  • 16.6. North America
    • 16.6.1. Canada
    • 16.6.2. Mexico
    • 16.6.3. United States
  • 16.7. Latin America
    • 16.7.1. Argentina
    • 16.7.2. Brazil
    • 16.7.3. Rest of Latin America

17. Company Profile

  • 17.1. Abbott Laboratories
    • 17.1.1. Company details
    • 17.1.2. Financial outlook
    • 17.1.3. Product summary
    • 17.1.4. Recent developments
  • 17.2. Accelerate Diagnostics Inc.
    • 17.2.1. Company details
    • 17.2.2. Financial outlook
    • 17.2.3. Product summary
    • 17.2.4. Recent developments
  • 17.3. Becton Dickinson and Co.
    • 17.3.1. Company details
    • 17.3.2. Financial outlook
    • 17.3.3. Product summary
    • 17.3.4. Recent developments
  • 17.4. Bio Rad Laboratories Inc.
    • 17.4.1. Company details
    • 17.4.2. Financial outlook
    • 17.4.3. Product summary
    • 17.4.4. Recent developments
  • 17.5. bioMerieux SA
    • 17.5.1. Company details
    • 17.5.2. Financial outlook
    • 17.5.3. Product summary
    • 17.5.4. Recent developments
  • 17.6. Bruker Corp.
    • 17.6.1. Company details
    • 17.6.2. Financial outlook
    • 17.6.3. Product summary
    • 17.6.4. Recent developments
  • 17.7. Danaher Corp
    • 17.7.1. Company details
    • 17.7.2. Financial outlook
    • 17.7.3. Product summary
    • 17.7.4. Recent developments
  • 17.8. DiaSorin SpA
    • 17.8.1. Company details
    • 17.8.2. Financial outlook
    • 17.8.3. Product summary
    • 17.8.4. Recent developments
  • 17.9. EKF Diagnostics Holdings Plc
    • 17.9.1. Company details
    • 17.9.2. Financial outlook
    • 17.9.3. Product summary
    • 17.9.4. Recent developments
  • 17.10. F. Hoffmann La Roche Ltd.
    • 17.10.1. Company details
    • 17.10.2. Financial outlook
    • 17.10.3. Product summary
    • 17.10.4. Recent developments
  • 17.11. GENERI BIOTECH s.r.o.
    • 17.11.1. Company details
    • 17.11.2. Financial outlook
    • 17.11.3. Product summary
    • 17.11.4. Recent developments
  • 17.12. Great Basin Scientific
    • 17.12.1. Company details
    • 17.12.2. Financial outlook
    • 17.12.3. Product summary
    • 17.12.4. Recent developments
  • 17.13. Hologic Inc.
    • 17.13.1. Company details
    • 17.13.2. Financial outlook
    • 17.13.3. Product summary
    • 17.13.4. Recent developments
  • 17.14. Meridian Bioscience Inc.
    • 17.14.1. Company details
    • 17.14.2. Financial outlook
    • 17.14.3. Product summary
    • 17.14.4. Recent developments
  • 17.15. Perkin Elmer Inc.
    • 17.15.1. Company details
    • 17.15.2. Financial outlook
    • 17.15.3. Product summary
    • 17.15.4. Recent developments
  • 17.16. QIAGEN NV
    • 17.16.1. Company details
    • 17.16.2. Financial outlook
    • 17.16.3. Product summary
    • 17.16.4. Recent developments
  • 17.17. Quest Diagnostics Inc.
    • 17.17.1. Company details
    • 17.17.2. Financial outlook
    • 17.17.3. Product summary
    • 17.17.4. Recent developments
  • 17.18. Siemens AG
    • 17.18.1. Company details
    • 17.18.2. Financial outlook
    • 17.18.3. Product summary
    • 17.18.4. Recent developments
  • 17.19. T2 Biosystems Inc.
    • 17.19.1. Company details
    • 17.19.2. Financial outlook
    • 17.19.3. Product summary
    • 17.19.4. Recent developments
  • 17.20. Takara Bio Inc.
    • 17.20.1. Company details
    • 17.20.2. Financial outlook
    • 17.20.3. Product summary
    • 17.20.4. Recent developments
  • 17.21. Others

18. List of Abbreviations

19. Reference Links

20. Conclusion

21. Research Scope

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!